Glaucoma Journal Club

Andreas Lauer

Institute for Mobile and Satellite Communication Technology

ORCIDOpenAlexGoogle ScholarResearchGateScopus

In this database

1

2025

DB Citations

16

across indexed articles

h-index

36

OpenAlex (all works)

Total Citations

5,803

OpenAlex (all works)

188 total publications (OpenAlex)78 i10-index

1 article in Glaucoma Journal Club

Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results.

Preliminary efficacy was observed at the maximum tolerated dose. Further studies are warranted to assess long-term safety and efficacy of AGTC-501 for XLRP treatment.

American journal of ophthalmology2025 Mar16 citations
visual-fieldneuroprotection